Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update shows an ongoing study evaluating stereotactic body radiotherapy for localized high-risk prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Adenocarcinoma of the Prostate, Stage III Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING